Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...

Medically reviewed by Corinne Savides Happel, MD Key Takeaways CPAP helps keep airways open and prevents breathing gaps ...

Asthma remains one of the most prevalent chronic diseases in the US. 3 Although poor adherence substantially contributes to inadequate outcomes, even patients with high adherence often experience ...

A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...

Dr. Marc Cromie with the Chattanooga Allergy Clinic joins News 12’s Chip Chapman at the start of the New Year with some health tips.  CHATTANOOGA, Tenn. (WDEF) – Flu season is here but best not to ...

A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms, a new trial has found. The drug, Tezepelumab (also known as Tezspir and ...

Biologics targeting inflammatory pathways have revolutionized asthma treatment. However, adherence and persistence remain a ...

GSK has secured approval from the US Food and Drug Administration (FDA) for its severe asthma add-on maintenance therapy, Exdensur (depemokimab). This means that the long-acting interleukin-5 ...

PARIS — Pregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright cessation of maintenance treatment, is common, ...

A new study shows that internet-delivered cognitive behavioural therapy (ICBT) can effectively reduce asthma-related anxiety ...